Could cause temporary or reversible harm; serious harm is unlikely.
Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2 mL vial.
| Brand name | SODIUM CHLORIDE |
| Generic name | SODIUM CHLORIDE |
| Active ingredient(s) | SODIUM CHLORIDE |
| Distributed by / for | Hikma Pharmaceuticals USA Inc. |
| NDC | 0641-0497-17 |
| Full product label | Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For use as a sterile diluent, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, a) Vial NDC 0641-0497-17, b) Carton of 25 vials NDC 0641-0497-25. |
| Recalling firm | Hikma Pharmaceuticals USA Inc. |
| Distribution | Nationwide in the U.S. |
| Quantity | 2,100,646 Vials |
| Recall initiated | 2020-11-03 |
| Report date | 2020-11-25 |
| Recall completed | 2022-11-17 |
| Recall number | D-0101-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Cherry Hill NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗